These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27422986)

  • 21. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glycoltic metabolism gene changes in left and right ventricles in experimental rat pulmonary arterial hypertension model].
    Qiu M; Zhang R; Zheng Y; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1010-6. PubMed ID: 25623347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
    Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
    J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting miR‑1 attenuates pulmonary arterial hypertension in rats.
    Liu Y; Li Y; Li J; Zuo X; Cao Q; Xie W; Wang H
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4.
    Wu Z; Geng J; Qi Y; Li J; Bai Y; Guo Z
    Pulm Circ; 2020; 10(4):2045894020974919. PubMed ID: 33354317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathway.
    Zhou C; Chen Y; Kang W; Lv H; Fang Z; Yan F; Li L; Zhang W; Shi J
    J Mol Cell Cardiol; 2019 May; 130():23-35. PubMed ID: 30858037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
    Veith C; Neghabian D; Luitel H; Wilhelm J; Egemnazarov B; Muntanjohl C; Fischer JH; Dahal BK; Schermuly RT; Ghofrani HA; Grimminger F; Fink L; Kwapiszewska G; Weissmann N; Sydykov A
    Basic Res Cardiol; 2020 Jan; 115(2):17. PubMed ID: 31980934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
    Ye L; Jiang Y; Zuo X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.
    Reddy S; Zhao M; Hu DQ; Fajardo G; Hu S; Ghosh Z; Rajagopalan V; Wu JC; Bernstein D
    Physiol Genomics; 2012 May; 44(10):562-75. PubMed ID: 22454450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
    Legchenko E; Chouvarine P; Borchert P; Fernandez-Gonzalez A; Snay E; Meier M; Maegel L; Mitsialis SA; Rog-Zielinska EA; Kourembanas S; Jonigk D; Hansmann G
    Sci Transl Med; 2018 Apr; 10(438):. PubMed ID: 29695452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-nitroso human serum albumin attenuates pulmonary hypertension, improves right ventricular-arterial coupling, and reduces oxidative stress in a chronic right ventricle volume overload model.
    Rungatscher A; Hallström S; Linardi D; Milani E; Gasser H; Podesser BK; Scarabelli TM; Luciani GB; Faggian G
    J Heart Lung Transplant; 2015 Mar; 34(3):479-88. PubMed ID: 25511748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.
    Tian L; Neuber-Hess M; Mewburn J; Dasgupta A; Dunham-Snary K; Wu D; Chen KH; Hong Z; Sharp WW; Kutty S; Archer SL
    J Mol Med (Berl); 2017 Apr; 95(4):381-393. PubMed ID: 28265681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    Gubrij IB; Pangle AK; Pang L; Johnson LG
    PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.
    Ma H; Ye P; Zhang AK; Yu WD; Lin S; Zheng YG
    Biomed Res Int; 2022; 2022():9294148. PubMed ID: 36246958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.